EP Patent

EP3111936A1 — Muscarinic acetylcholine receptor antagonists

Assigned to Glaxo Group Ltd · Expires 2017-01-04 · 9y expired

What this patent protects

Muscarinic Acetylcholine Receptor Antagonists and therapeutic methods of using them are provided.

USPTO Abstract

Muscarinic Acetylcholine Receptor Antagonists and therapeutic methods of using them are provided.

Drugs covered by this patent

Patent Metadata

Patent number
EP3111936A1
Jurisdiction
EP
Classification
—
Expires
2017-01-04
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.